CXCL10 and COVID-19: In the prognostic evaluation of GIP-10, it has shown a good sensitivity toward PF-associated COVID-19 prognosis with the area under the curve (AUC) of 0.885 and a cut-off value of 149.60 ng/mL in 87.8% sensitivity and 78.5% specificity (Figure 1).